AstraZeneca continued to see strong earnings boosted primarily by its oncology branch, as well as its respiratory and immunology segment.
Trending
- Clayface Trailer Sees DC Studios Go Body Horror
- The rise and fall of East Germany’s Palace of the Republic
- From pop royalty to raw Americana: 'Michael', 'The New West' and 'Die, My Love'
- ‘The Drama’ starring Zendaya, Robert Pattinson becomes fifth A24 film to cross $100m global box office | News
- Barbara Windsor – Latest news, tributes, pictures and more
- Rihanna, baby Rocki and Dior’s first ever couture diaper
- Can AI Ever Crack Taste?
- These 15 euro H&M pants are behind the revival of zebra print
